Glutathione S-transferase polymorphisms and colorectal cancer: a HuGE review.
暂无分享,去创建一个
[1] J. Witte,et al. Glutathione transferase null genotype, broccoli, and lower prevalence of colorectal adenomas. , 1998, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[2] T. Rushmore,et al. Glutathione S-transferases, structure, regulation, and therapeutic implications. , 1993, The Journal of biological chemistry.
[3] K. Golka,et al. Comparative genotyping and phenotyping of glutathione S-transferase GSTT1 , 1996, Archives of Toxicology.
[4] D. S. St. John,et al. Cancer Risk in Relatives of Patients with Common Colorectal Cancer , 1993, Annals of Internal Medicine.
[5] S. London,et al. Polymorphism of glutathione S-transferase M1 and lung cancer risk among African-Americans and Caucasians in Los Angeles County, California. , 1995, Journal of the National Cancer Institute.
[6] D. Christiani,et al. Glutathione S-transferase mu genotype, diet, and smoking as determinants of sister chromatid exchange frequency in lymphocytes. , 1995, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[7] C. Masimirembwa,et al. Phenotyping of the glutathione S-transferase M1 polymorphism in Zimbabweans and the effects of chloroquine on blood glutathione S-transferases M1 and A. , 1997, Clinica chimica acta; international journal of clinical chemistry.
[8] S. Garte. The role of ethnicity in cancer susceptibility gene polymorphisms: the example of CYP1A1. , 1998, Carcinogenesis.
[9] M. Pratt,et al. Physical activity and health , 1996, BMJ.
[10] J. Bruner,et al. Genetic polymorphisms in glutathione S-transferase mu and theta, N-acetyltransferase, and CYP1A1 and risk of gliomas. , 1998, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[11] M. Warholm,et al. Genotypic and phenotypic determination of polymorphic glutathione transferase T1 in a Swedish population. , 1995, Pharmacogenetics.
[12] G. Coetzee,et al. Glutathione S-transferase M1 genotype affects aminobiphenyl-hemoglobin adduct levels in white, black and Asian smokers and nonsmokers. , 1995, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[13] M. Leppert,et al. NAT2, GSTM-1, cigarette smoking, and risk of colon cancer. , 1998, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[14] J. Olsen,et al. Genotype and phenotype of glutathione S-transferase mu in testicular cancer patients. , 1997, Pharmacogenetics.
[15] P. Shields,et al. Genetic polymorphisms of the cancer related gene and Helicobacter pylori infection in Japanese gastric cancer patients: An age and gender matched case–control study , 1996, Cancer.
[16] Jack A. Taylor,et al. Genetic risk and carcinogen exposure: a common inherited defect of the carcinogen-metabolism gene glutathione S-transferase M1 (GSTM1) that increases susceptibility to bladder cancer. , 1993, Journal of the National Cancer Institute.
[17] Jacques Ferlay,et al. Cancer incidence in five continents. , 1976, IARC scientific publications.
[18] H Vainio,et al. The GSTM1 null genotype as a potential risk modifier for squamous cell carcinoma of the lung. , 1993, Carcinogenesis.
[19] Abelardo Avila-Curiel,et al. Food, nutrition and the prevention of cancer: a global perspective , 1998 .
[20] P. Knekt,et al. Smoking and risk of colorectal cancer. , 1998, British Journal of Cancer.
[21] N. Weiss,et al. The glutathione S-transferase mu polymorphism as a marker for susceptibility to lung carcinoma. , 1993, Cancer research.
[22] D. Bell,et al. Glutathione S-transferase GSTT1 genotypes and susceptibility to cancer: studies of interactions with GSTM1 in lung, oral, gastric and colorectal cancers. , 1996, Carcinogenesis.
[23] E. Lee,et al. Genetic polymorphism of conjugating enzymes and cancer risk: GSTM1, GSTT1, NAT1 and NAT2. , 1998, The Journal of toxicological sciences.
[24] A. Fryer,et al. Identification of polymorphism at the glutathione S-transferase, GSTM3 locus: evidence for linkage with GSTM1*A. , 1995, The Biochemical journal.
[25] A. Rannug,et al. Genetic susceptibility to lung cancer with special emphasis on CYP1A1 and GSTM1: a study on host factors in relation to age at onset, gender and histological cancer types. , 1994, Carcinogenesis.
[26] K. Hemminki,et al. Aromatic DNA adducts, micronuclei and genetic polymorphism for CYP1A1 and GST1 in chimney sweeps. , 1994, Carcinogenesis.
[27] D. Bell,et al. Association between glutathione S-transferase M1, P1, and T1 genetic polymorphisms and development of breast cancer. , 1998, Journal of the National Cancer Institute.
[28] P. Dayer,et al. Effects of glutathione S-transferases GSTM1 and GSTT1 genotypes on lung cancer risk in smokers. , 1997, Pharmacogenetics.
[29] J. Lear,et al. Susceptibility to multiple cutaneous basal cell carcinomas: significant interactions between glutathione S-transferase GSTM1 genotypes, skin type and male gender. , 1996, British Journal of Cancer.
[30] M. Schiffman,et al. Re: "Fried foods and the risk of colon cancer". , 1990, American journal of epidemiology.
[31] J. Högberg,et al. Polymorphic distribution of glutathione transferase activity with methyl chloride in human blood. , 1994, Pharmacogenetics.
[32] J. Manson,et al. Glutathione S-transferase class mu deletion polymorphism and breast cancer: results from prevalent versus incident cases. , 1997, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[33] J. Freudenheim,et al. Cytochrome P4501A1 and glutathione S-transferase (M1) genetic polymorphisms and postmenopausal breast cancer risk. , 1995, Cancer research.
[34] G. Webb,et al. Genetic heterogeneity of the human glutathione transferases: a complex of gene families. , 1990, Pharmacology & therapeutics.
[35] N K Spurr,et al. Relationship between the GSTM1 genetic polymorphism and susceptibility to bladder, breast and colon cancer. , 1993, Carcinogenesis.
[36] J. Ferlay,et al. Estimates of the worldwide incidence of eighteen major cancers in 1985 , 1993, International journal of cancer.
[37] J. Brockmöller,et al. Correlation between trans-stilbene oxide-glutathione conjugation activity and the deletion mutation in the glutathione S-transferase class mu gene detected by polymerase chain reaction. , 1992, Biochemical pharmacology.
[38] A. Fryer,et al. Theta class glutathione S-transferase GSTT1 genotypes and susceptibility to cervical neoplasia: interactions with GSTM1, CYP2D6 and smoking. , 1994, Carcinogenesis.
[39] A. Fryer,et al. Susceptibility to ulcerative colitis and Crohn's disease: interactions between glutathione S-transferase GSTM1 and GSTT1 genotypes. , 1995, Clinica chimica acta; international journal of clinical chemistry.
[40] M. Spitz,et al. Ethnic differences in the prevalence of the homozygous deleted genotype of glutathione S-transferase theta. , 1995, Carcinogenesis.
[41] J. Little,et al. The adenoma-carcinoma sequence and prospects for the prevention of colorectal neoplasia. , 1996, Critical reviews in oncogenesis.
[42] K. Noda,et al. Lung cancer risk of GSTM1 null genotype is dependent on the extent of tobacco smoke exposure. , 1994, Carcinogenesis.
[43] L Nyström,et al. Smoking and colorectal cancer: a 20-year follow-up study of Swedish construction workers. , 1996, Journal of the National Cancer Institute.
[44] G. Steineck,et al. Meat, cooking methods and colorectal cancer: A case‐referent study in Stockholm , 1991, International journal of cancer.
[45] S. Z. Abdel‐Rahman,et al. A multiplex PCR procedure for polymorphic analysis of GSTM1 and GSTT1 genes in population studies. , 1996, Cancer letters.
[46] R. Clayton,et al. The glutathione S-transferases: polymerase chain reaction studies on the frequency of the GSTM1 0 genotype in patients with pituitary adenomas. , 1993, Carcinogenesis.
[47] J. Lear,et al. Polymorphism at the glutathione S-transferase locus GSTM3: interactions with cytochrome P450 and glutathione S-transferase genotypes as risk factors for multiple cutaneous basal cell carcinoma. , 1996, Cancer research.
[48] H. Bolt,et al. Human glutathione S-transferase theta (GSTT1): cDNA cloning and the characterization of a genetic polymorphism. , 1994, The Biochemical journal.
[49] B. Mannervik,et al. Glutathione transferase activity and isoenzyme composition in primary human breast cancers. , 1990, Cancer research.
[50] H. Okkels,et al. Glutathione S-transferase mu as a risk factor in bladder tumours. , 1996, Pharmacogenetics.
[51] D. Bell,et al. Glutathione S-transferase M1 (GSTM1) and T1 (GSTT1) genetic polymorphism and susceptibility to gastric and colorectal adenocarcinoma. , 1996, Carcinogenesis.
[52] J. Lyon,et al. Fried foods and the risk of colon cancer. , 1988, American journal of epidemiology.
[53] R. Hayes,et al. The glutathione S-transferase M1 (GSTM1) null genotype and benzidine-associated bladder cancer, urine mutagenicity, and exfoliated urothelial cell DNA adducts. , 1996, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[54] A. Hirvonen. Genetic Factors in Individual Responses to Environmental Exposures , 1995, Journal of occupational and environmental medicine.
[55] J. Y. Park,et al. CYP1A1 and GSTM1 polymorphisms and oral cancer risk. , 1997, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[56] C. Bloomfield,et al. Increased risk for myelodysplastic syndromes in individuals with glutathione transferase theta 1 (GSTT1) gene defect , 1996, The Lancet.
[57] P. Couzigou,et al. Laryngeal and oropharyngeal cancer, and alcohol dehydrogenase 3 and glutathione S-transferase M1 polymorphisms , 1997, Human Genetics.
[58] M. Relling,et al. Simultaneous characterization of glutathione S-transferase M1 and T1 polymorphisms by polymerase chain reaction in American whites and blacks. , 1996, Pharmacogenetics.
[59] K. Kelsey,et al. Population-based study of glutathione S-transferase mu gene deletion in adult glioma cases and controls. , 1997, Carcinogenesis.
[60] R. Strange,et al. Glutathione S-transferase GSTM1 phenotypes and protection against cutaneous tumours , 1994, The Lancet.
[61] E. Wynder,et al. The consumption of well-done red meat and the risk of colorectal cancer. , 1994, American journal of public health.
[62] The World Health Report 1997--conquering suffering, enriching humanity. , 1997, World health forum.
[63] R. Doll,et al. Trends in cancer incidence and mortality , 1994 .
[64] E. Lee,et al. Frequency of mutant CYP1A1, NAT2 and GSTM1 alleles in normal Indians and Malays. , 1995, Pharmacogenetics.
[65] W. Willett,et al. A prospective study of cigarette smoking and risk of colorectal adenoma and colorectal cancer in U.S. women. , 1994, Journal of the National Cancer Institute.
[66] M. Esteller,et al. Susceptibility to endometrial cancer: influence of allelism at p53, glutathione S-transferase (GSTM1 and GSTT1) and cytochrome P-450 (CYP1A1) loci. , 1997, British Journal of Cancer.
[67] N. Weiss,et al. Glutathione S-transferase M1 genotypes and the risk of anal cancer: a population-based case-control study. , 1996, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[68] J. Hayes,et al. Allelism at the glutathione S-transferase GSTM3 locus: interactions with GSTM1 and GSTT1 as risk factors for astrocytoma. , 1996, Carcinogenesis.
[69] E. Lee,et al. Glutathione S transferase-theta (GSTT1) genetic polymorphism among Chinese, Malays and Indians in Singapore. , 1995, Pharmacogenetics.
[70] K. Nakachi,et al. Polymorphisms of the CYP1A1 and glutathione S-transferase genes associated with susceptibility to lung cancer in relation to cigarette dose in a Japanese population. , 1993, Cancer research.
[71] G A Colditz,et al. A prospective study of family history and the risk of colorectal cancer. , 1994, The New England journal of medicine.
[72] W. Farrell,et al. Epithelial ovarian cancer: influence of polymorphism at the glutathione S-transferase GSTM1 and GSTT1 loci on p53 expression. , 1996, British Journal of Cancer.
[73] T. Rebbeck. Molecular epidemiology of the human glutathione S-transferase genotypes GSTM1 and GSTT1 in cancer susceptibility. , 1997, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[74] Henry J. Lin,et al. Glutathione transferase (GSTM1) null genotype, smoking, and prevalence of colorectal adenomas. , 1995, Cancer research.
[75] L. Marchand,et al. CYP1A1 genetic polymorphisms and in situ colorectal cancer. , 1994, Cancer research.
[76] W. Pearson,et al. Homozygous deletion of gene for glutathione S-transferase M1 in bladder cancer. , 1993, BMJ.
[77] M. Leppert,et al. Meat consumption, genetic susceptibility, and colon cancer risk: a United States multicenter case-control study. , 1999, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[78] K. Kelsey,et al. Gene deletion of glutathione S-transferase theta: correlation with induced genetic damage and potential role in endogenous mutagenesis. , 1995, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[79] E. Rimm,et al. A prospective study of cigarette smoking and risk of colorectal adenoma and colorectal cancer in U.S. men. , 1994, Journal of the National Cancer Institute.
[80] V. Álvarez,et al. Genetic polymorphism of N-acetyltransferase-2, glutathione S-transferase-M1, and cytochromes P450IIE1 and P450IID6 in the susceptibility to head and neck cancer. , 1998, Journal of clinical pathology.
[81] C. Wolf,et al. Glutathione S-transferase mu locus: use of genotyping and phenotyping assays to assess association with lung cancer susceptibility. , 1991, Carcinogenesis.
[82] J. Hayes,et al. The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. , 1995, Critical reviews in biochemistry and molecular biology.
[83] W. Pearson,et al. Use of site-directed mutagenesis of allele-specific PCR primers to identify the GSTM1 A, GSTM1 B, GSTM1 A,B and GSTM1 null polymorphisms at the glutathione S-transferase, GSTM1 locus. , 1993, The Biochemical journal.
[84] C. J. Chen,et al. Cytochrome P450 2E1 and glutathione S-transferase M1 polymorphisms and susceptibility to hepatocellular carcinoma. , 1995, Gastroenterology.
[85] C. Matthias,et al. Glutathione S-transferase and cytochrome-P-450 polymorphism as risk factors for squamous cell carcinoma of the larynx. , 1996, American journal of surgery.
[86] J. Broome,et al. Susceptibility to astrocytoma and meningioma: influence of allelism at glutathione S-transferase (GSTT1 and GSTM1) and cytochrome P-450 (CYP2D6) loci. , 1995, Cancer research.
[87] K. Noda,et al. Increased risk of lung cancer in Japanese smokers with class mu glutathione S-transferase gene deficiency. , 1993, Cancer letters.
[88] D. Hunter,et al. Glutathione S-transferase GSTM1 and GSTT1 polymorphisms and colorectal cancer risk: a prospective study. , 1998, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[89] K. Comstock,et al. GST1 gene deletion determined by polymerase chain reaction. , 1990, Nucleic acids research.
[90] D. Bernstein,et al. Ethnic distribution of the glutathione transferase Mu 1-1 (GSTM1) null genotype in 1473 individuals and application to bladder cancer susceptibility. , 1994, Carcinogenesis.
[91] A. Mikelsaar,et al. Human glutathione S-transferase GSTM1 genetic polymorphism in Estonia. , 1994, Human heredity.
[92] N E Day,et al. The design of case-control studies: the influence of confounding and interaction effects. , 1984, International journal of epidemiology.
[93] C. Maugard,et al. Allelic deletion at glutathione S-transferase M1 locus and its association with breast cancer susceptibility. , 1998, Chemico-biological interactions.
[94] S. Z. Abdel‐Rahman,et al. Genetic polymorphism of GSTM1, CYP2E1 and CYP2D6 in Egyptian bladder cancer patients. , 1996, Carcinogenesis.
[95] C. Masimirembwa,et al. Genetic polymorphism of cytochrome P4501A1, microsomal epoxide hydrolase, and glutathione S-transferases M1 and T1 in Zimbabweans and Venda of southern Africa. , 1998, Pharmacogenetics.
[96] J. Rueff,et al. Glutathione S-transferase mu polymorphism and susceptibility to lung cancer in the Portuguese population. , 1996, Teratogenesis, carcinogenesis, and mutagenesis.
[97] M. Yano,et al. CYP1A1 CYP2E1 and GSTM1 polymorphisms are not associated with susceptibility to squamous‐cell carcinoma of the esophagus , 1997, International journal of cancer.
[98] M. Spitz,et al. Glutathione s-transferase genotypes as risk factors for head and neck cancer. , 1995, American journal of surgery.
[99] T. Reckwitz,et al. Glutathione S-transferase GSTM1 and GSTT1 null genotypes as potential risk factors for urothelial cancer of the bladder , 1996, Archives of Toxicology.
[100] J. Somberg. Genetic polymorphisms. , 2002, American journal of therapeutics.
[101] J. Mclaughlin,et al. Increased risk of colorectal cancer among smokers: Results of a 26‐year follow‐up of us veterans and a review , 1994, International journal of cancer.
[102] E. Lee,et al. Frequency of mutant CYPIA1, NAT2 and GSTM1 alleles in a normal Chinese population. , 1994, Pharmacogenetics.
[103] J. Brockmöller,et al. Combined analysis of inherited polymorphisms in arylamine N-acetyltransferase 2, glutathione S-transferases M1 and T1, microsomal epoxide hydrolase, and cytochrome P450 enzymes as modulators of bladder cancer risk. , 1996, Cancer research.
[104] T. Kawano,et al. Genetic polymorphisms of tobacco- and alcohol-related metabolizing enzymes and human esophageal squamous cell carcinoma susceptibility. , 1997, Journal of clinical gastroenterology.
[105] A. Santamaria,et al. Rapid detection of inducers of enzymes that protect against carcinogens. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[106] I. Roberts-Thomson,et al. Metabolic genotypes and risk for colorectal cancer , 2001, Journal of gastroenterology and hepatology.
[107] K. Buetow,et al. Susceptibility to hepatocellular carcinoma is associated with genetic variation in the enzymatic detoxification of aflatoxin B1. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[108] N. Roodi,et al. Breast cancer and CYPIA1, GSTM1, and GSTT1 polymorphisms: evidence of a lack of association in Caucasians and African Americans. , 1998, Cancer research.
[109] L. Rhodes. IARC Handbook of Cancer Prevention Sunscreens, vol. 5. , 2001 .